Urticaria

Recommendations for allergic emergencies are contained in the Respiratory chapter of the formulary.

Dermatology Pathways: Urticaria NICE CKS: Urticaria BAD Patient Information: Urticaria EAACI/GALEN/EDF/WAO: Urticaria guideline

Oral treatment of chronic urticaria
Cetirizine
Cetirizine 10mg tablets
Loratadine
Loratadine 10mg tablets
Fexofenadine
Fexofenadine 180mg tablets

Prescribing Notes:

  • Topical treatments may be helpful, see section on Pruritis for more information.

History Notes

27/05/2026

Regional formulary chapter launched.

Treatment of chronic spontaneous urticaria

As add-on therapy for the treatment of chronic spontaneous urticaria in adult and adolescent (12 years and above) patients with inadequate response to H1 antihistamine treatment.

Omalizumab
Omlyclo 150mg/1ml solution for injection pre-filled syringes
Omlyclo 150mg/1ml solution for injection pre-filled pens
Xolair 150mg/1ml solution for injection pre-filled pens
Xolair 300mg/2ml solution for injection pre-filled pens

History Notes

27/05/2026

Regional formulary chapter launched.

Oral treatment of chronic urticaria

Not licensed for children under 2 years.

Cetirizine
Cetirizine 10mg tablets
Cetirizine 1mg/ml oral solution sugar free
Loratadine
Loratadine 10mg tablets
Loratadine 5mg/5ml oral solution sugar free
Loratadine 5mg/5ml oral solution
Fexofenadine
Fexofenadine 180mg tablets

Prescribing Notes:

  • Topical treatments may be helpful, see section on Pruritis for more information.

History Notes

27/05/2026

Regional formulary chapter launched.

Treatment of chronic spontaneous urticaria

As add-on therapy for the treatment of chronic spontaneous urticaria in adult and adolescent (12 years and above) patients with inadequate response to H1 antihistamine treatment.

Omalizumab
Omlyclo 150mg/1ml solution for injection pre-filled syringes
Omlyclo 150mg/1ml solution for injection pre-filled pens
Xolair 150mg/1ml solution for injection pre-filled pens
Xolair 300mg/2ml solution for injection pre-filled pens

History Notes

27/05/2026

Regional formulary chapter launched.